Cargando…

PET image enhancement using artificial intelligence for better characterization of epilepsy lesions

INTRODUCTION: [(18)F]fluorodeoxyglucose ([(18)F]FDG) brain PET is used clinically to detect small areas of decreased uptake associated with epileptogenic lesions, e.g., Focal Cortical Dysplasias (FCD) but its performance is limited due to spatial resolution and low contrast. We aimed to develop a de...

Descripción completa

Detalles Bibliográficos
Autores principales: Flaus, Anthime, Deddah, Tahya, Reilhac, Anthonin, Leiris, Nicolas De, Janier, Marc, Merida, Ines, Grenier, Thomas, McGinnity, Colm J., Hammers, Alexander, Lartizien, Carole, Costes, Nicolas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708713/
https://www.ncbi.nlm.nih.gov/pubmed/36465898
http://dx.doi.org/10.3389/fmed.2022.1042706
_version_ 1784840996835557376
author Flaus, Anthime
Deddah, Tahya
Reilhac, Anthonin
Leiris, Nicolas De
Janier, Marc
Merida, Ines
Grenier, Thomas
McGinnity, Colm J.
Hammers, Alexander
Lartizien, Carole
Costes, Nicolas
author_facet Flaus, Anthime
Deddah, Tahya
Reilhac, Anthonin
Leiris, Nicolas De
Janier, Marc
Merida, Ines
Grenier, Thomas
McGinnity, Colm J.
Hammers, Alexander
Lartizien, Carole
Costes, Nicolas
author_sort Flaus, Anthime
collection PubMed
description INTRODUCTION: [(18)F]fluorodeoxyglucose ([(18)F]FDG) brain PET is used clinically to detect small areas of decreased uptake associated with epileptogenic lesions, e.g., Focal Cortical Dysplasias (FCD) but its performance is limited due to spatial resolution and low contrast. We aimed to develop a deep learning-based PET image enhancement method using simulated PET to improve lesion visualization. METHODS: We created 210 numerical brain phantoms (MRI segmented into 9 regions) and assigned 10 different plausible activity values (e.g., GM/WM ratios) resulting in 2100 ground truth high quality (GT-HQ) PET phantoms. With a validated Monte-Carlo PET simulator, we then created 2100 simulated standard quality (S-SQ) [(18)F]FDG scans. We trained a ResNet on 80% of this dataset (10% used for validation) to learn the mapping between S-SQ and GT-HQ PET, outputting a predicted HQ (P-HQ) PET. For the remaining 10%, we assessed Peak Signal-to-Noise Ratio (PSNR), Structural Similarity Index Measure (SSIM), and Root Mean Squared Error (RMSE) against GT-HQ PET. For GM and WM, we computed recovery coefficients (RC) and coefficient of variation (COV). We also created lesioned GT-HQ phantoms, S-SQ PET and P-HQ PET with simulated small hypometabolic lesions characteristic of FCDs. We evaluated lesion detectability on S-SQ and P-HQ PET both visually and measuring the Relative Lesion Activity (RLA, measured activity in the reduced-activity ROI over the standard-activity ROI). Lastly, we applied our previously trained ResNet on 10 clinical epilepsy PETs to predict the corresponding HQ-PET and assessed image quality and confidence metrics. RESULTS: Compared to S-SQ PET, P-HQ PET improved PNSR, SSIM and RMSE; significatively improved GM RCs (from 0.29 ± 0.03 to 0.79 ± 0.04) and WM RCs (from 0.49 ± 0.03 to 1 ± 0.05); mean COVs were not statistically different. Visual lesion detection improved from 38 to 75%, with average RLA decreasing from 0.83 ± 0.08 to 0.67 ± 0.14. Visual quality of P-HQ clinical PET improved as well as reader confidence. CONCLUSION: P-HQ PET showed improved image quality compared to S-SQ PET across several objective quantitative metrics and increased detectability of simulated lesions. In addition, the model generalized to clinical data. Further evaluation is required to study generalization of our method and to assess clinical performance in larger cohorts.
format Online
Article
Text
id pubmed-9708713
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97087132022-12-01 PET image enhancement using artificial intelligence for better characterization of epilepsy lesions Flaus, Anthime Deddah, Tahya Reilhac, Anthonin Leiris, Nicolas De Janier, Marc Merida, Ines Grenier, Thomas McGinnity, Colm J. Hammers, Alexander Lartizien, Carole Costes, Nicolas Front Med (Lausanne) Medicine INTRODUCTION: [(18)F]fluorodeoxyglucose ([(18)F]FDG) brain PET is used clinically to detect small areas of decreased uptake associated with epileptogenic lesions, e.g., Focal Cortical Dysplasias (FCD) but its performance is limited due to spatial resolution and low contrast. We aimed to develop a deep learning-based PET image enhancement method using simulated PET to improve lesion visualization. METHODS: We created 210 numerical brain phantoms (MRI segmented into 9 regions) and assigned 10 different plausible activity values (e.g., GM/WM ratios) resulting in 2100 ground truth high quality (GT-HQ) PET phantoms. With a validated Monte-Carlo PET simulator, we then created 2100 simulated standard quality (S-SQ) [(18)F]FDG scans. We trained a ResNet on 80% of this dataset (10% used for validation) to learn the mapping between S-SQ and GT-HQ PET, outputting a predicted HQ (P-HQ) PET. For the remaining 10%, we assessed Peak Signal-to-Noise Ratio (PSNR), Structural Similarity Index Measure (SSIM), and Root Mean Squared Error (RMSE) against GT-HQ PET. For GM and WM, we computed recovery coefficients (RC) and coefficient of variation (COV). We also created lesioned GT-HQ phantoms, S-SQ PET and P-HQ PET with simulated small hypometabolic lesions characteristic of FCDs. We evaluated lesion detectability on S-SQ and P-HQ PET both visually and measuring the Relative Lesion Activity (RLA, measured activity in the reduced-activity ROI over the standard-activity ROI). Lastly, we applied our previously trained ResNet on 10 clinical epilepsy PETs to predict the corresponding HQ-PET and assessed image quality and confidence metrics. RESULTS: Compared to S-SQ PET, P-HQ PET improved PNSR, SSIM and RMSE; significatively improved GM RCs (from 0.29 ± 0.03 to 0.79 ± 0.04) and WM RCs (from 0.49 ± 0.03 to 1 ± 0.05); mean COVs were not statistically different. Visual lesion detection improved from 38 to 75%, with average RLA decreasing from 0.83 ± 0.08 to 0.67 ± 0.14. Visual quality of P-HQ clinical PET improved as well as reader confidence. CONCLUSION: P-HQ PET showed improved image quality compared to S-SQ PET across several objective quantitative metrics and increased detectability of simulated lesions. In addition, the model generalized to clinical data. Further evaluation is required to study generalization of our method and to assess clinical performance in larger cohorts. Frontiers Media S.A. 2022-11-16 /pmc/articles/PMC9708713/ /pubmed/36465898 http://dx.doi.org/10.3389/fmed.2022.1042706 Text en Copyright © 2022 Flaus, Deddah, Reilhac, Leiris, Janier, Merida, Grenier, McGinnity, Hammers, Lartizien and Costes. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Medicine
Flaus, Anthime
Deddah, Tahya
Reilhac, Anthonin
Leiris, Nicolas De
Janier, Marc
Merida, Ines
Grenier, Thomas
McGinnity, Colm J.
Hammers, Alexander
Lartizien, Carole
Costes, Nicolas
PET image enhancement using artificial intelligence for better characterization of epilepsy lesions
title PET image enhancement using artificial intelligence for better characterization of epilepsy lesions
title_full PET image enhancement using artificial intelligence for better characterization of epilepsy lesions
title_fullStr PET image enhancement using artificial intelligence for better characterization of epilepsy lesions
title_full_unstemmed PET image enhancement using artificial intelligence for better characterization of epilepsy lesions
title_short PET image enhancement using artificial intelligence for better characterization of epilepsy lesions
title_sort pet image enhancement using artificial intelligence for better characterization of epilepsy lesions
topic Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9708713/
https://www.ncbi.nlm.nih.gov/pubmed/36465898
http://dx.doi.org/10.3389/fmed.2022.1042706
work_keys_str_mv AT flausanthime petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT deddahtahya petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT reilhacanthonin petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT leirisnicolasde petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT janiermarc petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT meridaines petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT grenierthomas petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT mcginnitycolmj petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT hammersalexander petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT lartiziencarole petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions
AT costesnicolas petimageenhancementusingartificialintelligenceforbettercharacterizationofepilepsylesions